ELEVATED SERUM AND SYNOVIAL FLUID LEVELS OF TUMOR NECROSIS FACTOR-LIKE LIGAND 1A AND DECOY RECEPTOR 3 IN RHEUMATOID ARTHRITIS: INDUCE INTERLEUKIN-17 PRODUCTION

被引：1
|
作者：
Shen, H. [1 ]
Xiu, Z. [1 ]
Tian, Y. [1 ]
Xia, L. [1 ]
Lu, J. [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Rheumatol, Shenyang 110001, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
TL1A;
D O I：
10.1136/annrheumdis-2014-eular.1415
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0065
引用
收藏
页码：825 / 825
页数：1
相关论文
共 50 条
  • [31] Tumor necrosis factor and norepinephrine lower the levels of human neutrophil peptides 1-3 secretion by mixed synovial tissue cultures in osteoarthritis and rheumatoid arthritis
    Riepl, Birgit
    Graessel, Susanne
    Wiest, Reiner
    Fleck, Martin
    Straub, Rainer H.
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (03)
  • [32] Tumor necrosis factor and norepinephrine lower the levels of human neutrophil peptides 1-3 secretion by mixed synovial tissue cultures in osteoarthritis and rheumatoid arthritis
    Birgit Riepl
    Susanne Grässel
    Reiner Wiest
    Martin Fleck
    Rainer H Straub
    Arthritis Research & Therapy, 12
  • [33] The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients
    Ihsan Ates
    Nihal Özkayar
    Fatma Akyel
    Canan Topcuoglu
    Serdar Akyel
    A Nurdan Barça
    Fatih Dede
    BMC Nephrology, 15
  • [34] The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients
    Ates, Ihsan
    Ozkayar, Nihal
    Akyel, Fatma
    Topcuoglu, Canan
    Akyel, Serdar
    Barca, A. Nurdan
    Dede, Fatih
    BMC NEPHROLOGY, 2014, 15
  • [35] Leishmanial lipid suppresses tumor necrosis factor α, interleukin-1β, and nitric oxide production by adherent synovial fluid mononuclear cells in rheumatoid arthritis patients and induces apoptosis through the mitochondrial-mediated pathway
    Majumdar, Kajal Nayan
    Banerjee, Aditi
    Ratha, Jagnyeswar
    Mandal, Mriganka
    Sarkar, Rathindra Nath
    Das Saha, Krishna
    ARTHRITIS AND RHEUMATISM, 2008, 58 (03): : 696 - 706
  • [36] Junctional adhesion molecules 2 and 3 are predominantly expressed in rheumatoid arthritis synovial fibroblasts and differentially regulated by interleukin-1 beta and tumor necrosis factor-alpha
    Masuda, K
    Masuda, R
    Bradfield, PF
    Imhof, BA
    Aurrand-Lions, M
    Simmen, BR
    Mueller-Ladner, U
    Michel, BA
    Gay, RE
    Gay, S
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S43 - S43
  • [37] Postoperative Serum Levels of Interleukin-1β (IL-1β), Interleukin-17 (IL-17), and Tumor Necrosis Factor-α (TNF-α) in Patients Following Hip Replacement Surgery for Traumatic Fractured Femoral Neck: A Retrospective Study
    Zhang, Hui
    Tai, Huiping
    Ma, Yuhong
    Li, Yan
    Dang, Zongping
    Wang, Junkai
    Zhao, Lin
    MEDICAL SCIENCE MONITOR, 2019, 25 : 6120 - 6127
  • [38] Dihydrotestosterone Inhibits Interleukin-1α or Tumor Necrosis Factor α-Induced Proinflammatory Cytokine Production via Androgen Receptor-Dependent Inhibition of Nuclear Factor-κB Activation in Rheumatoid Fibroblast-Like Synovial Cell Line
    Xu, Jian
    Itoh, Yuka
    Hayashi, Hidetoshi
    Takii, Takemasa
    Miyazawa, Keiji
    Onozaki, Kikuo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (11) : 1724 - 1730
  • [39] Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55
    Alsalameh, S
    Amin, RJ
    Kunisch, E
    Jasin, HE
    Kinne, RW
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1680 - 1690
  • [40] Elevated levels of insulin-like growth factor (IGF) binding protein-3 in rheumatoid arthritis synovial fluid inhibit stimulation by IGF-I of articular chondrocyte proteoglycan synthesis
    J. Neidel
    W. F. Blum
    H.-J. Schaeffer
    M. Schulze
    E. Schönau
    J. Lindschau
    J. Föll
    Rheumatology International, 1997, 17 : 29 - 37
12345